With the aim of protecting more and more Greek patients, a new product in Cardiovascular Medicine is launched. KERENDIA is now available for patients with CKD & Type 2 Diabetes. Welcome to Bayer Hellas internal Kerendia launch event, focusing on educating & preparing the Sales Team for a successful product promotion in the Greek market. In this event, you familiarized yourselves with the promotional materials & the role plays. This is the first POAP related to a pharmaceutical product. If you received this POAP, you are a True Pioneer in the Web3 space. Bayer is proudly promoting innovative practices. https://www.bayer.com/en/poap-tc

Experienced leader in development, validation, and implementation of clinical trial software and processes

Machine Learner, Bioinformatician, Pythonist. AMA!

I am a database programmer, I worked on various Oracle tools and Technologies. In Bayer I work for DaVE (Deviation and Validity environment) & ESRA Interpreter tool.